Europe’s Industrial Biotechnology: From Fermentation to Factory

On 6 October 2026, the Circular Bio-based Europe Joint Undertaking published a follow-up on CARBOSURF, describing how a European research collaboration contributed to industrial fermentation businesses. Its account connects Belgian pilot facilities, German industrial expertise and manufacturing in Slovakia. The business question is increasingly practical: what evidence turns a promising biological process into a dependable supply chain? CBE JU’s project follow-up

A technology with an industrial history

CARBOSURF ran from 1 August 2015 to 31 July 2018, coordinated by Ghent University. Its remit included improving microbial strains, fermentation and downstream processing for biosurfactants and specialty carbohydrates. The distinction matters technically: producing a useful molecule is only one stage; recovering and purifying it consistently is part of making a usable product. The project also included application testing and assessment across the value chain. European Commission project record

One outcome is visible in Slovenská Ľupča. Evonik announced its first product from an industrial-scale rhamnolipid plant on 18 January 2024 and its inauguration on 29 May 2024. These biosurfactants are made through fermentation using corn-derived feedstock and serve applications including cleaning and personal care. This is an established manufacturing milestone revisited in October’s report. The public announcements do not disclose plant-level profitability or independently benchmarked production costs. First-production announcement, inauguration announcement

A newer development at the same site needs a separate status label. On 14 September 2026, Evonik reported breaking ground on an approximately €80 million expansion for pharmaceutical-intermediate manufacturing. The company expects completion in early 2028 and approximately 50 new jobs. Those are forward-looking company statements; the expansion should not be counted as production capacity already available today. Evonik’s expansion update

Biotech Act II remains in preparation

The European Commission’s Biotech Act II workshop is scheduled for 12 October 2026 in Brussels, with online participation also listed. It will discuss preliminary options for industrial biotechnology and biomanufacturing, including demand and the transition away from fossil-based feedstocks. The Commission says the initiative’s exact scope will be determined through its impact assessment. As checked on 11 October, this is proposal preparation and consultation, not an enacted Biotech Act II or a new compliance deadline. Official workshop and programme

The Commission’s 18 May consultation notice had already identified investor predictability and demand in early markets as possible priorities. That earlier call closed on 10 June. Businesses reading today’s announcements should distinguish opportunities to follow policy development from an open funding competition, an available subsidy or permission to market a particular product. Commission consultation notice

What institutions can prepare now

For manufacturers, universities and prospective buyers, three questions provide a useful starting point:

• What has actually been demonstrated? Record the batch size, repeatability, purity, recovery yield and intended application. Keep pilot results, installed equipment and sustained commercial output separately identified.
• What makes supply dependable? Test feedstock availability, energy requirements, quality-control responsibilities and contingency arrangements. A biological production route needs a credible purchasing and delivery model alongside its scientific results.
• Who can use the resulting knowledge? Agree how collaborators may use strains, process improvements, test data and application know-how, including after a pilot ends or a partner withdraws.

These are practical due-diligence recommendations, not a statutory checklist. Environmental claims need equally clear boundaries: buyers should request the relevant lifecycle assessment, its assumptions and comparison product before relying on a general sustainability label. Neither a research award nor a supplier’s press release answers every procurement question.

For the KSC.JUSNREM ecosystem, a useful collaborative exercise would be a publicly sourced fermentation scale-up case study: one process, its evidence at each development stage, and the unresolved questions about contracts, data, intellectual property and purchasing. Researchers and industry participants can propose a non-confidential case through the existing research collaboration contact route. Any project would require its own agreed scope, responsibilities and terms.